Diagnostic value and clinical utility of contrast enhanced ultrasound in intestinal diseases

Digestive and Liver Disease

Volumn 42, Issue 10, 2010, Pages 667-674

  Braden, Barbara ^a   Ignee, Andre ^b   Hocke, Michael ^b,c   Palmer, Rebecca M ^a   Dietrich, Christoph ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CARITAS KRANKENHAUS   (Germany)

^c Klinikum Meiningen   (Germany)

Author keywords

Bowel wall; Complication; Contrast agent; Inflammatory bowel disease

Indexed keywords

APPENDICITIS; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DIVERTICULITIS; ENTERITIS; ENTEROPATHY; GASTROINTESTINAL TUMOR; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE HEMATOMA; INTESTINE ISCHEMIA; INTUSSUSCEPTION; MESENTERY BLOOD FLOW; NEUTROPENIC ENTEROCOLITIS; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; ULCERATIVE COLITIS; ULTRASOUND;

CONTRAST MEDIA; HUMANS; INTESTINAL DISEASES; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 77956285030     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.05.018     Document Type: Short Survey

References (65)

1. Hirche T.O., Russler J., Schroder O., et al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002, 37:1178-1183.
2. Parente F., Greco S., Molteni M., et al. Imaging inflammatory bowel disease using bowel ultrasound. Eur J Gastroenterol Hepatol 2005, 17:283-291.
3. Esteban J.M., Maldonado L., Sanchiz V., et al. Activity of Crohn's disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol 2001, 11:1423-1428.
4. Spalinger J., Patriquin H., Miron M.C., et al. Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000, 217:787-791.
5. Rapaccini G.L., Pompili M., Orefice R., et al. Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 2004, 39:188-194.
6. Gorce J.M., Arditi M., Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of SonoVue. Invest Radiol 2000, 35:661-671.
7. Greis C. Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004, 14(Suppl. 8):P11-15.
8. Kersting S., Konopke R., Kersting F., et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology 2009, 137:1903-1911.
9. Calabrese E., La Seta F., Buccellato A., et al. Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema. Inflamm Bowel Dis 2005, 11:139-145.
10. Dietrich C.F., Jedrzejczyk M., Ignee A. Sonographic assessment of splanchnic arteries and the bowel wall. Eur J Radiol 2007, 64:202-212.
11. Ludwig D., Wiener S., Bruning A., et al. Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study. Gut 1999, 45:546-552.
12. Ludwig D., Wiener S., Bruning A., et al. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study. Am J Gastroenterol 1999, 94:2942-2950.
13. Homann N., Klarmann U., Fellermann K., et al. Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease. Inflamm Bowel Dis 2005, 11:126-132.
14. Ignee A., Jedrejczyk M., Schuessler G., et al. Quantitative contrast enhanced ultrasound of the liver for time intensity curves-reliability and potential sources of errors. Eur J Radiol 2009.
15. Pauls S., Gabelmann A., Schmidt S.A., et al. Evaluating bowel wall vascularity in Crohn's disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 2006, 16:2410-2417.
16. Di Sabatino A., Fulle I., Ciccocioppo R., et al. Doppler enhancement after intravenous Levovist injection in Crohn's disease. Inflamm Bowel Dis 2002, 8:251-257.
17. Girlich C., Jung E.M., Iesalnieks I., et al. Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 2009, 43:141-148.
18. Kratzer W., Schmidt S.A., Mittrach C., et al. Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): a new technique for quantifying bowel wall vascularity in Crohn's disease. Scand J Gastroenterol 2005, 40:985-991.
19. Schreyer A.G., Finkenzeller T., Gossmann H., et al. Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008, 40:143-155.
20. De Pascale A., Garofalo G., Perna M., et al. Contrast-enhanced ultrasonography in Crohn's disease. Radiol Med 2006, 111:539-550.
21. Robotti D., Cammarota T., Debani P., et al. Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 2004, 29:648-652.
22. Plikat K., Klebl F., Buchner C., et al. Evaluation of intestinal hyperaemia in inflamed bowel by high resolution Contrast Harmonic Imaging (CHI). Ultraschall Med 2004, 25:257-262.
23. Migaleddu V., Scanu A.M., Quaia E., et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 2009, 137:43-52.
24. Serra C., Menozzi G., Labate A.M., et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007, 62:114-121.
25. Ripolles T., Martinez M.J., Paredes J.M., et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009, 253:241-248.
26. Kunihiro K., Hata J., Manabe N., et al. Predicting the need for surgery in Crohn's disease with contrast harmonic ultrasound. Scand J Gastroenterol 2007, 42:577-585.
27. Guidi L., De Franco A., De Vitis I., et al. Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease. Eur Rev Med Pharmacol Sci 2006, 10:23-26.
28. Quaia E., Migaleddu V., Baratella E., et al. The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 2009, 69:438-444.
29. Esteban J.M., Aleixandre A., Hurtado M.J., et al. Contrast-enhanced power Doppler ultrasound in the diagnosis and follow-up of inflammatory abdominal masses in Crohn's disease. Eur J Gastroenterol Hepatol 2003, 15:253-259.
30. Sallomi D.F. The use of contrast-enhanced power Doppler ultrasound in the diagnosis and follow-up of inflammatory abdominal masses associated with Crohn's disease. Eur J Gastroenterol Hepatol 2003, 15:249-251.
31. Volkmer B.G., Nesslauer T., Kufer R., et al. Diagnosis of vesico-intestinal fistulas by contrast medium enhanced 3-D ultrasound. Ultraschall Med 2001, 22:81-86.
32. Maconi G., Carsana L., Fociani P., et al. Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther 2003, 18:749-756.
33. Maconi G., Greco S., Duca P., et al. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease. Inflamm Bowel Dis 2008, 14:1555-1561.
34. Kratzer W., von Tirpitz C., Mason R., et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn's disease. J Ultrasound Med 2002, 21:149-157. quiz 158-149.
35. Schlottmann K., Kratzer W., Scholmerich J. Doppler ultrasound and intravenous contrast agents in gastrointestinal tract disorders: current role and future implications. Eur J Gastroenterol Hepatol 2005, 17:263-275.
36. Yamaguchi T., Yoshida S., Tanaka S., et al. Predicting the clinical response to cytapheresis in steroid-refractory or -dependent ulcerative colitis using contrast-enhanced ultrasonography. Scand J Gastroenterol 2009, 44:831-837.
37. Kessler N., Cyteval C., Gallix B., et al. Appendicitis: evaluation of sensitivity, specificity, and predictive values of US, Doppler US, and laboratory findings. Radiology 2004, 230:472-478.
38. Je B.K., Kim S.B., Lee S.H., et al. Diagnostic value of maximal-outer-diameter and maximal-mural-thickness in use of ultrasound for acute appendicitis in children. World J Gastroenterol 2009, 15:2900-2903.
39. Gaitini D., Beck-Razi N., Mor-Yosef D., et al. Diagnosing acute appendicitis in adults: accuracy of color Doppler sonography and MDCT compared with surgery and clinical follow-up. Am J Roentgenol 2008, 190:1300-1306.
40. Catalano O., Nunziata A., Sandomenico F., et al. Acute flank pain: comparison of unenhanced helical CT and ultrasonography in detecting causes other than ureterolithiasis. Emerg Radiol 2002, 9:146-154.
41. Patriquin H.B., Garcier J.M., Lafortune M., et al. Appendicitis in children and young adults: Doppler sonographic-pathologic correlation. Am J Roentgenol 1996, 166:629-633.
42. Incesu L., Yazicioglu A.K., Selcuk M.B., et al. Contrast-enhanced power Doppler US in the diagnosis of acute appendicitis. Eur J Radiol 2004, 50:201-209.
43. Lameris W., van Randen A., Bipat S., et al. Graded compression ultrasonography and computed tomography in acute colonic diverticulitis: meta-analysis of test accuracy. Eur Radiol 2008, 18:2498-2511.
44. Gorg C., Egbring J., Bert T. Contrast-enhanced ultrasound of epiploic appendagitis. Ultraschall Med 2009, 30:163-167.
45. Dietrich C.F., Lembcke B., Seifert H., et al. Ultrasound diagnosis of penicillin-induced segmental hemorrhagic colitis. Dtsch Med Wochenschr 2000, 125:755-760.
46. Ludolph T., Schmidt-Wilcke H.A. Ultrasound diagnosis of pseudomembranous colitis. Dtsch Med Wochenschr 2000, 125:750-754.
47. Gorschluter M., Glasmacher A., Hahn C., et al. Severe abdominal infections in neutropenic patients. Cancer Invest 2001, 19:669-677.
48. Downey D.B., Wilson S.R. Pseudomembranous colitis: sonographic features. Radiology 1991, 180:61-64.
49. Dietrich C.F., Hermann S., Klein S., et al. Sonographic signs of neutropenic enterocolitis. World J Gastroenterol 2006, 12:1397-1402.
50. Klein S.A., Martin H., Schreiber-Dietrich D., et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001, 115:929-934.
51. Stranzinger E., Dipietro M.A., Yarram S., et al. Intramural and subserosal echogenic foci on US in large-bowel intussusceptions: prognostic indicator for reducibility?. Pediatr Radiol 2009, 39:42-46.
52. Hanquinet S., Anooshiravani M., Vunda A., et al. Reliability of color Doppler and power Doppler sonography in the evaluation of intussuscepted bowel viability. Pediatr Surg Int 1998, 13:360-362.
53. Kong M.S., Wong H.F., Lin S.L., et al. Factors related to detection of blood flow by color Doppler ultrasonography in intussusception. J Ultrasound Med 1997, 16:141-144.
54. Hamada T., Yamauchi M., Tanaka M., et al. Prospective evaluation of contrast-enhanced ultrasonography with advanced dynamic flow for the diagnosis of intestinal ischaemia. Br J Radiol 2007, 80:603-608.
55. Hata J., Kamada T., Haruma K., et al. Evaluation of bowel ischemia with contrast-enhanced US: initial experience. Radiology 2005, 236:712-715.
56. Drelich-Zbroja A., Jargiello T., Szymanska A., et al. The diagnostic value of Levovist in Doppler imaging of visceral arteries in patients with abdominal angina before and after angioplasty. Eur J Ultrasound 2003, 16:225-235.
57. Fukuta N., Kitano M., Maekawa K., et al. Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonics US. J Gastroenterol 2005, 40:247-255.
58. Lassau N., Chami L., Benatsou B., et al. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 2007, 17(Suppl. 6):F89-98.
59. Lassau N., Lamuraglia M., Chami L., et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am J Roentgenol 2006, 187:1267-1273.
60. Fraquelli M., Sarno A., Girelli C., et al. Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease. Dig Liver Dis 2008, 40:860-866.
61. Romanini L., Passamonti M., Aiani L., et al. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007, 17(Suppl. 6):F99-F106.
62. Faccioli N., D'Onofrio M., Comai A., et al. Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 2007, 112:810-820.
63. Nurnberg D., Jung A., Schmieder C., et al. What's the price of routine sonography-results of an analysis of costs and processes in a district hospital. Ultraschall Med 2008, 29:405-417.
64. Giesel F.L., Delorme S., Sibbel R., et al. Contrast-enhanced ultrasound for the characterization of incidental liver lesions-an economical evaluation in comparison with multi-phase computed tomography. Ultraschall Med 2009, 30:259-268.
65. Schuler A, Reuss J, Delorme S, et al. Costs of clinical ultrasound examinations-an economical cost calculation and analysis. Ultraschall Med. 2010 Feb 24 [Epub ahead of print].